Caribou Biosciences, Inc. Common Stock Share Price
NASDAQ: CRBUHealthcare
Live Caribou Biosciences, Inc. Common Stock Share Price Chart
O H L
Caribou Biosciences, Inc. Common Stock Performance Overview
Days Range
▼
$1.32Low
$1.33High
Markets Today
| Previous Close | $1.31 |
|---|---|
| Open | $1.33 |
| Volume | 145,608 |
| Day's Range | $1.32 - $1.33 |
| 52W Range | $1.25 - $3.54 |
| Market Cap | $134.01 M |
Historical Performance
| 1M Returns | -16.03 |
|---|---|
| 3M Returns | -20.12 |
| 6M Returns | -31.41 |
| 1Y Returns | -26.40 |
| 5Y Returns | -94.67 |
| 10Y Returns | NA |
Caribou Biosciences, Inc. Common Stock Fundamentals
| Market Cap | $134.01 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $11.16 M |
| ROE TTM | -0.79 |
| EPS TTM | $-1.08 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.35 |
| EBITDA | $-132.55 M |
| Profit Margin | -1328.77 |
| Market Cap | $134.01 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $11.16 M |
| ROE TTM | -0.79 |
| EPS TTM | $-1.08 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.35 |
| EBITDA | $-132.55 M |
| Profit Margin | -1328.77 |
Caribou Biosciences, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.35 M | $2.67 M | $2.20 M | $3.94 M | $2.40 M | $1.50 M |
| Gross Profit + | $2.35 M | $2.67 M | $2.20 M | $3.94 M | $2.40 M | $1.50 M |
| Operating Income | -$42.91 M | -$47.58 M | -$29.40 M | -$28.45 M | -$26.28 M | -$25.34 M |
| EBITDA | -$41.75 M | -$34.26 M | -$28.77 M | -$27.77 M | -$25.63 M | -$24.71 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $1.17 M | $13.32 M | $631.00 K | $682.00 K | $649.00 K | $625.00 K |
| Income Before Tax | -$39.99 M | -$54.10 M | -$27.55 M | -$27.04 M | -$25.09 M | -$24.28 M |
| Income Tax Expense | $0 | $0 | $0 | -$550.00 K | $0 | $0 |
| Net Income + | -$39.99 M | -$54.10 M | -$27.55 M | -$26.49 M | -$25.09 M | -$24.28 M |
| Net Profit Margin | -1699.58% | -2028.42% | -1253.32% | -672.11% | -1046.52% | -1619.88% |
Caribou Biosciences, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $9.00 K | $9.00 K | $9.00 K | $9.00 K | $10.00 K | $11.00 K |
| Reserve & Surplus | -$488.21 M | -$542.44 M | -$569.93 M | -$596.41 M | -$621.62 M | -$645.95 M |
| Non-Current Liabilities | $27.94 M | $25.88 M | $25.08 M | $27.78 M | $27.31 M | $26.70 M |
| Current Liabilities | $28.49 M | $28.89 M | $28.06 M | $25.41 M | $19.67 M | $17.97 M |
| Total Liabilities | $56.43 M | $54.77 M | $53.14 M | $53.19 M | $46.98 M | $44.67 M |
| Fixed Assets | $18.52 M | $8.18 M | $7.60 M | $6.76 M | $6.12 M | $5.50 M |
| Current Assets | $217.32 M | $192.51 M | $155.51 M | $145.23 M | $122.38 M | $116.59 M |
| Total Assets | $273.66 M | $220.90 M | $194.98 M | $175.37 M | $149.00 M | $142.77 M |
Caribou Biosciences, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$39.99 M | -$54.10 M | -$27.55 M | -$26.49 M | -$25.09 M | -$24.28 M |
| Operating Cash Flow | -$36.73 M | -$28.26 M | -$25.18 M | -$20.82 M | -$26.98 M | -$22.79 M |
| Investing Cash Flow | $49.38 M | $24.04 M | $10.85 M | $17.97 M | $23.98 M | $18.94 M |
| Financing Cash Flow | $468.00 K | $6.00 K | $277.00 K | $4.07 M | $2.70 M | $17.94 M |
| Change in Cash | $13.12 M | -$4.22 M | -$14.06 M | $1.22 M | -$303.00 K | $14.09 M |
Caribou Biosciences, Inc. Common Stock Return Calculator
The Caribou Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$533
Invested Amount$10,000
Est. Returns$-9,467
About Caribou Biosciences, Inc. Common Stock
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Popular Stocks
FAQs
What is the share price of Caribou Biosciences, Inc. Common Stock today?
Caribou Biosciences, Inc. Common Stock (CRBU) share price as of September 18, 2026 is $1.31. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Caribou Biosciences, Inc. Common Stock?
Yes, Indian Investors can invest in the Caribou Biosciences, Inc. Common Stock (CRBU) Share by opening an international trading account with Angel One.
How can I purchase Caribou Biosciences, Inc. Common Stock shares in India?
Purchasing Caribou Biosciences, Inc. Common Stock (CRBU) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Caribou Biosciences, Inc. Common Stock (CRBU) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Caribou Biosciences, Inc. Common Stock?
Yes, you can purchase fractional shares of Caribou Biosciences, Inc. Common Stock (CRBU) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Caribou Biosciences, Inc. Common Stock?
The market capitalization of Caribou Biosciences, Inc. Common Stock on September 18, 2026, is $134.01 M.
In which sector Caribou Biosciences, Inc. Common Stock belongs?
Caribou Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Caribou Biosciences, Inc. Common Stock stocks?
In order to invest in Caribou Biosciences, Inc. Common Stock (CRBU) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
